HOME >> BIOLOGY >> NEWS
In Nature paper, scientists at U.Va. health system crack part of 'histone' code

CHARLOTTESVILLE, Va., Jan. 12, 2005 Little is known about the specific role of histones - the protein 'spool' around which the famous DNA double helix is folded.

Now, researchers at the University of Virginia Health System have unraveled one mystery about what histones accomplish in the complex chemical cascade that determines the function of a cell in the body. Their findings are published in the Jan. 12, 2005 online edition of the journal Nature.

Scientists at U.Va's Department of Biochemistry and Molecular Genetics discovered that a previously known protein called Chd1 recognizes a flag (or code) on histones and physically binds to a certain mark (a methylation mark.) The protein Chd1 then attracts a huge complex of other proteins, called SAGA, that can turn genes on in the cell nucleus.

"This is a good example of how proteins respond to the histone code," explained study senior author Patrick Grant, PhD, an Assistant Professor of Biochemistry and Molecular Genetics at U.Va. "There is a theory, proposed by Dr David Allis at Rockefeller University and Dr Brian Strahl at the University of North Carolina, that DNA does not function in isolation. Rather, its' function can be dictated by this modification of histones, which can determine whether DNA is exposed and accessible or not. This takes us one step closer to understanding how chemical information carried on histones, rather than DNA, is recognized and read during the regulation of genes."

Chd1 mutation has been linked to a rare neurological disease called CHARGE syndrome that causes birth defects, including eye abnormalities, facial palsy and swallowing problems, blocked nasal passages, heart defects and delayed development. Already, Grant and his colleagues are working in the lab on a project involving the role of SAGA proteins in another rare neurological disorder called spinal cerebellar ataxia type 7 that causes neurodegeneration and blindness. Grant believes that
'"/>

Contact: Bob Beard
reb8e@virginia.edu
434-982-4490
University of Virginia Health System
12-Jan-2005


Page: 1 2

Related biology news :

1. Natures weapon against nerve agents
2. Natures secrets yield new adhesive material
3. Nature surrenders flowery secrets to international team
4. Nature Genetics and the International Society of Nephrology come to Danvers on World Kidney Day
5. UCSB study on sibling detection mechanism highlighted in Nature
6. USC study in Nature Genetics supports a stem cell origin of cancer
7. Biolex reports potential for more potent, efficacious antibodies in Nature Biotechnology
8. Natures process for nitrogen fixation caught in action
9. Origen publishes in Nature a robust and versatile method for creating transgenic chickens
10. FSU scientists biomolecular research published in Science, Nature
11. Nature meets technology at Georgia Techs conference on bio-inspired design

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Nature paper scientists health system crack part histone code

(Date:5/22/2013)... and human health effects from disposal of millions ... scientists to recommend stronger government policies to encourage ... materials. That,s the conclusion of a new paper ... Technology . , Oladele A. Ogunseitan and colleagues ... for powering everything from smart phones to components ...
(Date:5/22/2013)... important new details on how climate change will affect ... in the Journal of Animal Ecology . This ... and informing policymakers of how species are likely to ... is a growing recognition among biologists that climate change ... that this is going to have very important consequences ...
(Date:5/22/2013)... YORK, May 22, 2013. Plastic additives known as ... about everywhere: They turn up in flooring, plastic ... to the Centers for Disease Control and Preventionthe ... phthalates have come under increasing scrutiny. A growing ... (which can leech from packaging and mix with ...
Breaking Biology News(10 mins):UCLA life scientists present new insights on climate change and species interactions 2UCLA life scientists present new insights on climate change and species interactions 3UCLA life scientists present new insights on climate change and species interactions 4UCLA life scientists present new insights on climate change and species interactions 5Study links chemicals widely found in plastics and processed food to elevated blood pressure in children and teens 2
(Date:5/23/2013)... NY (PRWEB) May 23, 2013 ... GRAPHALLOY® self-lubricating bushings mounted in stainless steel ... self-lubricating properties of GRAPHALLOY with the application and ... Stainless Steel Pillow Blocks work exceptionally well ... corrosive or hostile liquids such as acids, alkalies, ...
(Date:5/23/2013)... The maker community is a contemporary ... They focus on learning practical skills while applying them ... bringing their ideas to life via crowdfunding. A subgroup ... making projects using biology. Glowing Plant has worked for ... them glow with bioluminescence genes, and has now pursued ...
(Date:5/23/2013)... 2013 Virobay, Inc. today announced that their ... an important milestone, as Virobay has now initiated a ... cathepsin S inhibitor.   The first Phase ... study designed to evaluate the safety, tolerability, pharmacokinetics and ... "The initiation of this Phase 1 trial ...
(Date:5/23/2013)... -- Northwest Biotherapeutics (NASDAQ: NWBO ) (NW ... immune therapies for solid tumor cancers, announced today that ... Society Of Clinical Oncology (ASCO) meeting in ... immune therapy.  (Logo: http://photos.prnewswire.com/prnh/20110329/SF73084LOGO ) ... conference focused on clinical treatment of cancer, with attendance ...
Breaking Biology Technology:Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 2Graphite Metallizing Now Offers GRAPHALLOY® Stainless Steel Pillow Blocks for Success in Submersible Applications 3Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3
Cached News: